Clinical Trials
CTI BioPharma To Submit NDA For Pacritinib In Q4 Based Primarily On Data From Single Pivotal Persist-1 Trial
CTI BioPharma Corp. announced its plan to submit a new drug application (NDA) to the U.S. Food and Drug Administration (FDA) following a productive...
Research Insight
ASCO hail cancer immunotherapy as clinical cancer advance of the year
In their just-released Clinical Cancer Advances 2016: ASCO’s Annual Report on Progress Against Cancer the American Society of Clinical Oncology (ASCO) has today hailed...
Press Releases
Early diagnosis of bowel cancer in the England – Report Highlights
The importance of national screening Data published by Cancer Research UK and Public Health England’s National Cancer Intelligence Network have reported, for the first...
Research Insight
Study Finds High Proportion of Advanced Breast Cancers in sub-Saharan Africa
In one of the first studies of its kind, a new report finds a large majority of breast cancers in Cote d’Ivoire and Republic...
Clinical Trials
Pivotal Phase 3 Studies of Bezlotoxumab, Merck’s Investigational Antitoxin to Prevent Clostridium Difficile Infection Recurrence, Met Primary Endpoint
Merck known as MSD outside the United States and Canada, today announced that the two pivotal Phase 3 clinical studies for bezlotoxumab, its investigational...
News
Merck and Tridonic Enter Into License Agreement for White LEDs
Merck, a leading company for innovative and top-quality high-tech products in the healthcare, life science and performance materials sectors, announced today that it has...
Research Insight
Cancer Remains Leading Cause of Death in U.S. Hispanics
While cancer is the second leading cause of death overall in the United States, it remains the leading cause of death among U.S. Hispanics....
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read